Vicor Technologies, Inc. (VCRT.OB) Receives 510(k) Approval to Market Its PD2i Analyzer
Vicor Technologies, Inc. announced today the receipt of FDA 510(k) approval (K082709) to market its PD2i Analyzer. The PD2i Analyzer utilizes Vicor's patented, proprietary point correlation dimension algorithm (PD2i), a deterministic, non-linear measure that assesses ECG data, to provide physicians with insight into heart rate complexity over time. David H. Fater, President and CEO of Vicor, stated, "FDA 510(k) approval to commercialize the PD2i Analyzer is a milestone for Vicor. The intended use of the Vicor PD2i Analyzer is to display and analyze electrocardiographic information and to measure heart rate complexity. The clinical significance of heart rate variability, and other…